# EDGAR Filing Document

**Accession Number:** 0001980845
**File Stem:** 0001193125-26-074564
**Filing Date:** 2026-2
**Character Count:** 2165
**Document Hash:** defbc66a44283f3851be2497e4e12949
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-074564.hdr.sgml**: 20260401

**ACCESSION NUMBER**: 0001193125-26-074564

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260226

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** enGene Holdings Inc.
- **CENTRAL INDEX KEY:** 0001980845
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** Z4
- **FISCAL YEAR END:** 1031

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 4868 RUE LEVY, SUITE 220
- **CITY:** SAINT-LAURENT
- **STATE:** A8
- **ZIP:** H4R 2P1
- **BUSINESS PHONE:** (514) 332-4888

**MAIL ADDRESS:**
- **STREET 1:** 4868 RUE LEVY, SUITE 220
- **CITY:** SAINT-LAURENT
- **STATE:** A8
- **ZIP:** H4R 2P1

**enGene Holdings Inc.**

4868 Rue Levy, Suite 220

Saint-Laurent, QC H4R2P1

(514) 332-4888

February 26, 2026

**<u>VIA EDGAR</u>**

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Mr. Jimmy McNamara

**Re: enGene Holdings Inc.**

**Registration Statement on Form S-3**

**Filed February 19, 2026**

**File No. 333-293597** 

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, enGene Holdings Inc. hereby requests acceleration of the effective date of the above-referenced registration statement on Form S-3, so that such registration statement may become effective at 4:00 P.M. (Washington, D.C. time) on March 2, 2026, or as soon as practicable thereafter.

The Registrant hereby authorizes David Bionghi, of Morgan, Lewis & Bockius LLP to orally modify or withdraw this request for acceleration.

Please contact David Bionghi of Morgan, Lewis & Bockius LLP at +1.212.309.6138 or david.bionghi@morganlewis.com with any questions you may have concerning this request, and please notify him when this request for acceleration has been granted.

**enGene Holdings Inc.**

By: <u>/s/ Ronald H.W. Cooper</u> 

Name: Ronald H.W. Cooper

Title: Chief Executive Officer

------